T cell receptor-dependent activation of mTOR signaling in T Cells Is Mediated by Carma1 and MALT1, but not Bcl10

Science Signaling

Volumn 7, Issue 329, 2014, Pages

  Hamilton, Kristia S ^a   Phong, Binh ^a   Corey, Catherine ^a   Cheng, Jing ^a   Gorentla, Balachandra ^b   Zhong, Xiaoping ^b   Shiva, Sruti ^a   Kane, Lawrence P ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; CASPASE; CASPASE RECRUITMENT DOMAIN CONTAINING MEMBRANE ASSOCIATED PROTEIN 1; CD28 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA PROTEIN 1; PROTEIN BCL 10; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CATALYSIS; CD4+ T LYMPHOCYTE; CELL METABOLISM; CELL PROLIFERATION; CELL STIMULATION; COMPLEX FORMATION; CONTROLLED STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

EID: 84902651290     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.2004983     Document Type: Article

References (66)

1. D. D. Sarbassov, S. M. Ali, D. M. Sabatini, Growing roles for the mTOR pathway. Curr. Opin. Cell Biol. 17, 596-603 (2005).
2. M. Laplante, D. M. Sabatini, mTOR signaling in growth control and disease. Cell 149, 274-293 (2012).
3. S. Wullschleger, R. Loewith, M. N. Hall, TOR signaling in growth and metabolism. Cell 124, 471-484 (2006).
4. I. Ruvinsky, O. Meyuhas, Ribosomal protein S6 phosphorylation: From protein synthesis to cell size. Trends Biochem. Sci. 31, 342-348 (2006).
5. S. G. Ward, Phosphoinositide 3-kinases and leukocyte migration. Curr. Immunol. Rev. 8, 154-160 (2013).
6. L. V. Sinclair, D. Finlay, C. Feijoo, G. H. Cornish, A. Gray, A. Ager, K. Okkenhaug, T. J. Hagenbeek, H. Spits, D. A. Cantrell, Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking. Nat. Immunol. 9, 513-521 (2008).
7. S. Sulic, L. Panic, M. Barkic, M. Mercep, M. Uzelac, S. Volarevic, Inactivation of S6 ribosomal protein gene in T lymphocytes activates a p53-dependent checkpoint response. Genes Dev. 19, 3070-3082 (2005).
8. D. A. Cantrell, Regulation and function of serine kinase networks in lymphocytes. Curr. Opin. Immunol. 15, 294-298 (2003).
9. M. M. Juntilla, G. A. Koretzky, Critical roles of the PI3K/Akt signaling pathway in T cell development. Immunol. Lett. 116, 104-110 (2008).
10. L. P. Kane, A. Weiss, The PI-3 kinase/Akt pathway and T cell activation: Pleiotropic pathways downstream of PIP3. Immunol. Rev. 192, 7-20 (2003).
11. A. N. Macintyre, D. Finlay, G. Preston, L. V. Sinclair, C. M. Waugh, P. Tamas, C. Feijoo, K. Okkenhaug, D. A. Cantrell, Protein kinase B controls transcriptional programs that direct cytotoxic T cell fate but is dispensable for T cell metabolism. Immunity 34, 224-236 (2011).
12. M. Blonska, B. P. Pappu, R. Matsumoto, H. Li, B. Su, D. Wang, X. Lin, The CARMA1-Bcl10 signaling complex selectively regulates JNK2 kinase in the T cell receptorsignaling pathway. Immunity 26, 55-66 (2007).
13. T. Che, Y. You, D. Wang, M. J. Tanner, V. M. Dixit, X. Lin, MALT1/paracaspase is a signaling component downstream of CARMA1 and mediates T cell receptor-induced NF-kB activation. J. Biol. Chem. 279, 15870-15876 (2004).
14. O. Gaide, B. Favier, D. F. Legler, D. Bonnet, B. Brissoni, S. Valitutti, C. Bron, J. Tschopp, M. Thome, CARMA1 is a critical lipid raft-associated regulator of TCR-induced NF-[κ]B activation. Nat. Immunol. 3, 836-843 (2002).
15. J. r. Ruland, G. S. Duncan, A. Elia, I. del Barco Barrantes, L. Nguyen, S. Plyte, D. G. Millar, D. Bouchard, A. Wakeham, P. S. Ohashi, T. W. Mak, Bcl10 is a positive regulator of antigen receptor-induced activation of NF-kB and neural tube closure. Cell 104, 33-42 (2001).
16. G. Lenz,R. E. Davis, V.N. Ngo, L. Lam, T. C. George, G.W.Wright, S. S. Dave, H. Zhao, W. Xu, A. Rosenwald, G. Ott, H. K. Muller-Hermelink, R. D. Gascoyne, J. M. Connors, L. M. Rimsza, E. Campo, E. S. Jaffe, J. Delabie, E. B. Smeland, R. I. Fisher, W. C. Chan, L. M. Staudt, Oncogenic CARD11 mutations in human diffuse large B cell lymphoma. Science 319, 1676-1679 (2008).
17. G. Lenz, G. W. Wright, N. C. T. Emre, H. Kohlhammer, S. S. Dave, R. E. Davis, S. Carty, L. T. Lam, A. L. Shaffer, W. Xiao, J. Powell, A. Rosenwald, G. Ott, H. K. Muller-Hermelink, R. D. Gascoyne, J. M. Connors, E. Campo, E. S. Jaffe, J. Delabie, E. B. Smeland, L. M. Rimsza, R. I. Fisher, D. D. Weisenburger, W. C. Chan, L. M. Staudt, Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways. Proc. Natl. Acad. Sci. U.S.A. 105, 13520-13525 (2008).
18. V. N. Ngo, R. E. Davis, L. Lamy, X. Yu, H. Zhao, G. Lenz, L. T. Lam, S. Dave, L. Yang, J. Powell, L. M. Staudt, A loss-of-function RNA interference screen for molecular targets in cancer. Nature 441, 106-110 (2006).
19. A. L. Shaffer, A. Rosenwald, L. M. Staudt, Lymphoid malignancies: The dark side of B-cell differentiation. Nat. Rev. Immunol. 2, 920-932 (2002).
20. B. Coornaert, M. Baens, K. Heyninck, T. Bekaert, M. Haegman, J. Staal, L. Sun, Z. J. Chen, P. Marynen, R. Beyaert, T cell antigen receptor stimulation induces MALT1 paracaspase - mediated cleavage of the NF-k B inhibitor A20. Nat. Immunol. 9, 263-271 (2008).
21. F. Rebeaud, S. Hailfinger, A. Posevitz-Fejfar, M. Tapernoux, R. Moser, D. Rueda, O. Gaide, M. Guzzardi, E. M. Iancu, N. Rufer, N. Fasel, M. Thome, The proteolytic activity of the paracaspase MALT1 is key in T cell activation. Nat. Immunol. 9, 272-281 (2008).
22. J. Staal, T. Bekaert, R. Beyaert, Regulation of NF-κB signaling by caspases and MALT1 paracaspase. Cell Res. 21, 40-54 (2011).
23. S. M. Schieke, D. Phillips, J. P. McCoy, A. M. Aponte, R. F. Shen, R. S. Balaban, T. Finkel, The mammalian target of rapamycin (mTOR) pathway regulates mitochondrial oxygen consumption and oxidative capacity. J. Biol. Chem. 281, 27643-27652 (2006).
24. K. Yang, H. Chi, mTOR and metabolic pathways in T cell quiescence and functional activation. Semin. Immunol. 24, 421-428 (2012).
25. P. Narayan, B. Holt, R. Tosti, L. Kane, CARMA1 is required for Akt-mediated NF-κB activation in T cells. Mol. Cell. Biol. 26, 2327-2336 (2006).
26. D. Wang, Y. You, S. M. Case, L. M. McAllister-Lucas, L.Wang, P. S. DiStefano, G. Nuñez, J.Bertin, X. Lin, A requirement forCARMA1 inTCR-inducedNF-kB activation. Nat. Immunol. 3, 830-835 (2002).
27. L. R. Pearce, D. Komander, D. R. Alessi, The nuts and bolts of AGC protein kinases. Nat. Rev. Mol. Cell Biol. 11, 9-22 (2010).
28. M. Laplante, D. M. Sabatini,mTORsignaling at a glance. J. Cell Sci. 122, 3589-3594 (2009).
29. I. Tato, R. Bartrons, F. Ventura, J. L. Rosa, Amino acids activate mammalian target of rapamycin complex 2 (mTORC2) via PI3K/Akt signaling. J. Biol. Chem. 286, 6128-6142 (2011).
30. T. Chatila, L. Silverman, R. Miller, R. Geha, Mechanisms of T cell activation by the calcium ionophore ionomycin. J. Immunol. 143, 1283-1289 (1989).
31. H. Hara, T.Wada, C. Bakal, I. Kozieradzki, S. Suzuki, N. Suzuki, M. Nghiem, E. K. Griffiths, C. Krawczyk, B. Bauer, F. D'Acquisto, S. Ghosh,W. C. Yeh, G. Baier, R. Rottapel, J. M. Penninger, The MAGUK family protein CARD11 is essential for lymphocyte activation. Immunity 18, 763-775 (2003).
32. J. D. Powell, G. M. Delgoffe, The mammalian target of rapamycin: Linking T cell differentiation, function, and metabolism. Immunity 33, 301-311 (2010).
33. A. Mondino, D. L. Mueller, mTOR at the crossroads of T cell proliferation and tolerance. Semin. Immunol. 19, 162-172 (2007).
34. D. M. Sabatini, mTOR and cancer: Insights into a complex relationship. Nat. Rev. Cancer 6, 729-734 (2006).
35. M. Thome, R. Weil, Post-translational modifications regulate distinct functions of CARMA1 and BCL10. Trends Immunol. 28, 281-288 (2007).
36. S. F. Barnett, D. Defeo-Jones, S. Fu, P. J. Hancock, K.M. Haskell, R. E. Jones, J. A. Kahana, A. M. Kral, K. Leander, L. L. Lee, J. Malinowski, E. M. McAvoy, D. D. Nahas, R. G. Robinson, H. E. Huber, Identification and characterization of pleckstrin-homology-domaindependent and isoenzyme-specific Akt inhibitors. Biochem. J. 385, 399-408 (2005).
37. M. Thome, CARMA1, BCL-10 and MALT1 in lymphocyte development and activation. Nat. Rev. Immunol. 4, 348-359 (2004).
38. M. Thome, J. E. Charton, C. Pelzer, S. Hailfinger, Antigen receptor signaling to NF-κB via CARMA1, BCL10, and MALT1. Cold Spring Harb. Perspect. Biol. 2, a003004 (2010).
39. C. J. Wu, J. D. Ashwell, NEMO recognition of ubiquitinated Bcl10 is required for T cell receptor-mediated NF-kB activation. Proc. Natl. Acad. Sci. U.S.A. 105, 3023-3028 (2008).
40. S. Hailfinger, G. Lenz, V. Ngo, A. Posvitz-Fejfar, F. Rebeaud, M. Guzzardi, E. M. M. Penas, J. Dierlamm, W. C. Chan, L. M. Staudt, M. Thome, Essential role of MALT1 protease activity in activated B cell-like diffuse large B-cell lymphoma. Proc. Natl. Acad. Sci. U.S.A. 106, 19946-19951 (2009).
41. L. Sun, L. Deng, C. K. Ea, Z. P. Xia, Z. J. Chen, The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes. Mol. Cell 14, 289-301 (2004).
42. S. W. Evans, W. L. Farrar, Interleukin 2 and diacylglycerol stimulate phosphorylation of 40 S ribosomal S6 protein. Correlation with increased protein synthesis and S6 kinase activation. J. Biol. Chem. 262, 4624-4630 (1987).
43. E. L. Pearce, Metabolism in T cell activation and differentiation. Curr. Opin. Immunol. 22, 314-320 (2010).
44. J. C. Rathmell, M. G. V. Heiden, M. H. Harris, K. A. Frauwirth, C. B. Thompson, In the absence of extrinsic signals, nutrient utilization by lymphocytes is insufficient to maintain either cell size or viability. Mol. Cell 6, 683-692 (2000).
45. A. L. Edinger, C. B. Thompson, Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake. Mol. Biol. Cell 13, 2276-2288 (2002).
46. R. L. Lamason, A. Kupfer, J. L. Pomerantz, The dynamic distribution of CARD11 at the immunological synapse is regulated by the inhibitory kinesin GAKIN. Mol. Cell 40, 798-809 (2010).
47. J. Bertin, Y. Guo, L. Wang, S. M. Srinivasula, M. D. Jacobson, J. L. Poyet, S. Merriam, M. Q. Du, M. J. S. Dyer, K. E. Robison, P. S. DiStefano, E. S. Alnemri, CARD9 is a novel caspase recruitment domain containing protein that interacts with BCL10/CLAP and activates NF-κB. J. Biol. Chem. 275, 41082-41086 (2000).
48. X. F. Zheng, S. L. Schreiber, Target of rapamycin proteins and their kinase activities are required for meiosis. Proc. Natl. Acad. Sci. U.S.A. 94, 3070-3075 (1997).
49. S. Hailfinger, H. Nogai, C. Pelzer, M. Jaworski, K. Cabalzar, J. E. Charton, M. Guzzardi, C. Dacaillet, M. Grau, B. Durken, P. Lenz, G. Lenz, M. Thome, Malt1-dependent RelB cleavage promotes canonical NF-κB activation in lymphocytes and lymphoma cell lines. Proc. Natl. Acad. Sci. U.S.A. 108, 14596-14601 (2011).
50. H. Kawadler, M. A. Gantz, J. L. Riley, X. Yang, The paracaspase MALT1 controls caspase-8 activation during lymphocyte proliferation. Mol. Cell 31, 415-421 (2008).
51. A. F. Arechiga, B. D. Bell, S. Leverrier, B. M.Weist, M. Porter, Z. Wu, Y. Kanno, S. J. Ramos, S. T. Ong, R. Siegel, C. M. Walsh, A Fas-associated death domain protein/caspase-8-signaling axis promotes S-phase entry and maintains S6 kinase activity in T cells responding to IL-2. J. Immunol. 179, 5291-5300 (2007).
52. J. Staal, Y. Driege, T. Bekaert, A. Demeyer, D. Muyllaert, P. Van Damme, K. Gevaert, R. Beyaert, T-cell receptor-induced JNK activation requires proteolytic inactivation of CYLD by MALT1. EMBO J. 30, 1742-1752 (2011).
53. T. Uehata, H. Iwasaki, A. Vandenbon, K. Matsushita, E. Hernandez-Cuellar, K. Kuniyoshi, T. Satoh, T. Mino, Y. Suzuki, D. M. Standley, T. Tsujimura, H. Rakugi, Y. Isaka, O. Takeuchi, S. Akira, Malt1-induced cleavage of Regnase-1 in CD4+ helper T cells regulates immune activation. Cell 153, 1036-1049 (2013).
54. J. Faridi, J. Fawcett, L. Wang, R. A. Roth, Akt promotes increased mammalian cell size by stimulating protein synthesis and inhibiting protein degradation. Am. J. Physiol. Endocrinol. Metab. 285, E964-E972 (2003).
55. D. C. Fingar, S. Salama, C. Tsou, E. Harlow, J. Blenis, Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. Genes Dev. 16, 1472-1487 (2002).
56. J. De, R. Brown, Tissue-microarray based immunohistochemical analysis of survival pathways in nodular sclerosing classical Hodgkin lymphoma as compared with Non-Hodgkin's lymphoma. Int. J. Clin. Exp. Med. 3, 55-68 (2010).
57. L. V. Pham, A. T. Tamayo, C. Li, W. Bornmann, W. Priebe, R. J. Ford, Degrasyn potentiates the antitumor effects of bortezomib in mantle cell lymphoma cells in vitro and in vivo: Therapeutic implications. Mol. Cancer Ther. 9, 2026-2036 (2010).
58. T. E. Witzig, M. Gupta, Signal transduction inhibitor therapy for lymphoma. Hematology Am. Soc. Hematol. Educ. Program 2010, 265-270 (2010).
59. A. P. Kelly, D. K. Finlay, H. J. Hinton, R. G. Clarke, E. Fiorini, F. Radtke, D. A. Cantrell, Notch-induced T cell development requires phosphoinositide-dependent kinase 1. EMBO J. 26, 3441-3450 (2007).
60. H. Chi, Regulation and function of mTOR signalling in T cell fate decisions. Nat. Rev. Immunol. 12, 325-338 (2012).
61. A. T. Waickman, J. D. Powell, Mammalian target of rapamycin integrates diverse inputs to guide the outcome of antigen recognition in T cells. J. Immunol. 188, 4721-4729 (2012).
62. H. Zeng, H. Chi, mTOR and lymphocyte metabolism. Curr. Opin. Immunol. 25, 347-355 (2013).
63. J. Cheng, B. Phong, D. C. Wilson, R. Hirsch, L. P. Kane, Akt fine-tunes NF-κB-dependent gene expression during T cell activation. J. Biol. Chem. 286, 36076-36085 (2011).
64. J. Lee, E.W. Su, C. Zhu, S. Hainline, J. Phuah, J. A. Moroco, T. E. Smithgall, V. K. Kuchroo, L. P. Kane, Phosphotyrosine-dependent coupling of Tim-3 to T-cell receptor signaling pathways. Mol. Cell. Biol. 31, 3963-3974 (2011).
65. T. van Meerten, R. S. van Rijn, S. Hol, A. Hagenbeek, S. B. Ebeling, Complementinduced cell death by rituximab depends on CD20 expression level and acts complementary to antibody-dependent cellular cytotoxicity. Clin. Cancer Res. 12, 4027-4035 (2006).
66. M. E. Heid, P. A. Keyel, C. Kamga, S. Shiva, S. C. Watkins, R. D. Salter, Mitochondrial reactive oxygen species induces NLRP3-dependent lysosomal damage and inflammasome activation. J. Immunol. 191, 5230-5238 (2013).